 Aim 3 exploratory: To conduct a mixed methods formative evaluation that will guide REVAMPs widespread implementation. Quantitative component: The investigators will track quantitative outcome measures across both groups including attrition, participant- and practitioner-rated therapeutic alliance Working Alliance Inventory-Short Revised WAI-SR,9 and participant treatment satisfaction Client Satisfaction Questionnaire CSQ-8.10 The investigators will compare the scores of the WAI-SR and CSQ-8 and attrition rates between treatment arms. Qualitative component: The investigators will explore participant- and practitioner-level perspectives, attitudes, and preferences regarding REVAMP versus in-person management, as well as barriers and facilitators to participation in either clinical pathway through phone interviews with participants from the two intervention groups, participants who withdraw from either intervention, and staff who provide care through REVAMP. 